Greyhound Racing NSW (GRNSW) stewards inquired into analysts’ reports that the urine sample taken from Yellow Stone – after that greyhound had won Race 1 at the Casino Greyhound Club’s meeting on 22 March 2013 – had been analysed and confirmed to contain the testosterone metabolite 5beta-androstane-3alpha, 17beta-diol at a level in excess of 10 ng/ml in urine as specified in GAR 83 (6) as an exempted level in urine taken from a bitch.
Evidence was taken from trainer Chinchilla-Angel Carter-King and Australian Racing Forensic Laboratory (ARFL) Science Manager Dr Adam Cawley. Written evidence was submitted from ARFL Senior Veterinarian Dr Craig Suann, the ARFL, Racing Science Centre Qld and GRNSW.
The inquiry heard Ms Carter-King had adopted a practice of administration of .25 mls of the testosterone containing preparation Tepro on either the Sunday or Monday each week, irrespective of the racing date of any bitch in her care. Tepro is known to contain twice the level of testosterone propionate than that contained in the recommended product for oestrus suppression, testoprop, given at that level fortnightly. This occurred despite warnings on Tepro and other preparations given to participants in written material and seminars during September, October and November 2012.
Ms Carter-King subsequently pleaded guilty to a charge under GAR 83 (2) (a) in that she presented Yellow Stone for the race in question other than free of any prohibited substance due to the urine sample taken from the bitch after the race was found on confirmatory analysis to have contained 5beta-androstane-3alpha, 17beta-diol in excess of the threshold level of 10 ng/ml.
Following submissions on penalty and having regard to her financial circumstances, Ms Carter-King was suspended for a period of six months.
In assessing penalty consideration was given to Ms Carter-King’s previously unblemished record over nearly 13 years of registration, her guilty plea, her personal circumstances, the low activity rate of starters in her care and a low number of samples submitted previously, her co-operation during the inquiry and at notification of the irregularity, and the absence of any significant kennel support for Yellow Stone.
Notwithstanding these factors a measure of negligence had been shown in the administration of Tepro, leading to an extremely high level of the metabolite reported, and that a measure of both specific and general deterrence should be implied in these circumstances.
Yellow Stone was disqualified from the event and the placings amended accordingly.